PRO DEX INC
Business
Pro-Dex, Inc. designs, develops, and manufactures autoclavable, battery-powered and electric surgical drivers and shavers for orthopedic, thoracic, and craniomaxillofacial markets, along with rotary air motors. The company holds patented adaptive torque-limiting technology and proprietary sealing solutions. Products are sold primarily to original equipment manufacturers and medical device distributors through exclusive development and supply agreements. The company operates manufacturing and assembly facilities in Irvine and Tustin, California.
Summary from 10-K filed 2025-09-04
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Net sales | 67 | 54 | 46 | 42 | 38 | |
| Cost of sales | 47 | 39 | 33 | 29 | 24 | |
| Gross profit | 20 | 15 | 13 | 13 | 14 | |
| Selling expenses | 344,000 | 117,000 | 155,000 | 91,000 | 590,000 | |
| General and administrative expenses | 5 | 4 | 4 | 5 | 4 | |
| Research and development costs | 4 | 3 | 3 | 3 | 4 | |
| Total operating expenses | 9 | 7 | 7 | 8 | 9 | |
| Operating income | 11 | 7 | 6 | 5 | 5 | |
| Interest and dividend income | 82,000 | 144,000 | 294,000 | 76,000 | 126,000 | |
| Unrealized gain (loss) on marketable equity investments | 2 | −4 | 4 | 931,000 | 2 | |
| Gain on sale of investments | 595,000 | — | 6,000 | 28,000 | 1 | |
| Interest expense | −829,000 | −558,000 | −533,000 | — | — | |
| Total other income (expense) | 1 | −5 | 4 | 571,000 | 3 | |
| Income before income taxes | 12 | 3 | 9 | 6 | 8 | |
| Income tax expense | −3 | −507,000 | 2 | 1 | 1 | |
| Net income | 9 | 2 | 7 | 5 | 6 | |
| Basic net income per share | 2.73 | 0.61 | 1.98 | 1.26 | 1.63 | |
| Diluted net income per share | 2.67 | 0.6 | 1.95 | 1.21 | 1.57 | |
| Basic | 3 | 3 | 4 | 4 | 4 | |
| Diluted | 3 | 4 | 4 | 4 | 4 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2023 2023-03-31 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 419,000 | 3 | 3 | — | — | |
| Investments | 7 | 4 | 1 | — | — | |
| Accounts receivable | 16 | 14 | 10 | — | — | |
| Deferred costs | 24,000 | 262,000 | 494,000 | — | — | |
| Inventory | 22 | 15 | 16 | — | — | |
| Income taxes receivable | 1 | — | — | — | — | |
| Prepaid expenses | 410,000 | 345,000 | 296,000 | — | — | |
| Total current assets | 47 | 37 | 31 | — | — | |
| Land and building, net | 6 | 6 | 6 | — | — | |
| Equipment and improvements, net | 5 | 5 | 5 | — | — | |
| Right of use asset, net | 1 | 1 | 2 | — | — | |
| Intangibles, net | 26,000 | 54,000 | 81,000 | — | — | |
| Deferred income taxes, net | 1 | 2 | 0 | — | — | |
| Investments | 148,000 | 2 | 8 | 7 | 7 | |
| Other assets | 44,000 | 42,000 | 42,000 | — | — | |
| Total assets | 61 | 52 | 52 | 52 | 52 | |
| Accounts payable | 5 | 5 | 2 | — | — | |
| Accrued liabilities | 3 | 3 | 3 | — | — | |
| Income taxes payable | 186,000 | 632,000 | 453,000 | — | — | |
| Deferred revenue | 202,000 | 14,000 | 0 | — | — | |
| Notes payable | 6 | 4 | 4 | — | — | |
| Total current liabilities | 15 | 13 | 10 | — | — | |
| Lease liability, net of current portion | 685,000 | 1 | 2 | — | — | |
| Notes payable, net of current portion | 9 | 8 | — | — | — | |
| Total non-current liabilities | 10 | 9 | 11 | — | — | |
| Total liabilities | 25 | 22 | 20 | 22 | 24 | |
| Common stock, no par value, 50,000,000 shares authorized; 3,261,043 and 3,363,412 shares issued and outstanding at June 30, 2025 and 2024, respectively | 704,000 | 4 | 7 | — | — | |
| Retained earnings | 36 | 27 | 25 | 23 | 22 | |
| Total shareholders equity | 37 | 31 | 32 | — | — | |
| Total liabilities and shareholders equity | 61 | 52 | 52 | 52 | 52 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 1 | 1 | 857,000 | 726,000 | 686,000 | |
| Unrealized (gain) loss on marketable equity investments | −2 | 4 | −4 | −931,000 | −2 | |
| Gain on sale of investments | −595,000 | — | −6,000 | −28,000 | −1 | |
| Non-cash straight-line lease amortization | −33,000 | −17,000 | — | — | — | |
| Amortization of loan fees, net | 9,000 | 12,000 | 12,000 | 9,000 | 49,000 | |
| Share-based compensation | 555,000 | 605,000 | 766,000 | 1 | 901,000 | |
| Deferred income taxes | 140,000 | −2 | 264,000 | −63,000 | 89,000 | |
| Accounts receivable | −3 | −4 | 5 | −4 | −6 | |
| Deferred costs | 238,000 | 232,000 | 216,000 | −517,000 | −38,000 | |
| Inventory | −7 | 898,000 | −3 | −4 | −199,000 | |
| Prepaid expenses and other assets | −67,000 | −49,000 | — | −331,000 | −314,000 | |
| Accounts payable and accrued expenses | 179,000 | 2 | −1 | 2 | 105,000 | |
| Deferred revenue | 188,000 | 14,000 | −1 | 863,000 | −50,000 | |
| Income taxes | −2 | 179,000 | −91,000 | 147,000 | −408,000 | |
| Net cash provided by (used in) operating activities | −2 | 6 | 5 | −847,000 | −2 | |
| Purchases of equipment and improvements | −1 | −983,000 | −974,000 | −2 | −2 | |
| Proceeds from sale of investments | 2 | — | 89,000 | 770,000 | 5 | |
| Investment in Monogram | −899,000 | −1 | 0 | −334,000 | — | |
| Net cash used in investing activities | −238,000 | −2 | −885,000 | −1 | −4 | |
| Principal payments on notes payable | −12 | −5 | −6 | −1 | −351,000 | |
| Borrowing from Minnesota Bank & Trust | 15 | 4 | 5 | — | — | |
| Repurchases of common stock | −4 | −4 | −2 | −2 | −6 | |
| Payments of employee taxes on net issuance of common stock | −305,000 | — | −223,000 | — | — | |
| Proceeds from exercise of stock options and ESPP contributions | 42,000 | 50,000 | 89,000 | 60,000 | 96,000 | |
| Net cash used in financing activities | −292,000 | −4 | −2 | −790,000 | 3 | |
| Net decrease in cash and cash equivalents | −2 | −305,000 | 2 | −3 | −3 | |
| Cash paid during the period for interest | 818,000 | 555,000 | 521,000 | 463,000 | 330,000 | |
| Federal income tax payments | 3 | 2 | — | — | — | |
| California income tax payments | 1 | 334,000 | — | — | — | |
| Colorado income tax payments | — | 8,000 | — | — | — | |
| Massachusetts income tax payments | — | 34,000 | — | — | — | |
| Total income tax payments | 4 | 2 | 2 | 2 | 2 | |
| Cashless stock option exercise | 117,000 | — | — | — | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is PRO DEX INC's CIK number?
PRO DEX INC's SEC CIK number is 0000788920 (788920). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find PRO DEX INC's SEC filings?
All of PRO DEX INC's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did PRO DEX INC last report earnings?
PRO DEX INC (PDEX) most recently filed an earnings 8-K with the SEC on Apr 30, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001079973-26-000581). This is PRO DEX INC's most recent earnings filing of record — not a forecast of its next earnings date.
What is PRO DEX INC's most recent earnings 8-K?
PRO DEX INC's latest earnings 8-K (Item 2.02) was filed Apr 30, 2026 under accession 0001079973-26-000581. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View PRO DEX INC's latest earnings 8-K →
Look up any company's CIK number →